Novavax CEO Stanley Erck and CureVac CEO Franz-Werner Haas (Andrew Harnik/AP Images; Christoph Schmidt/picture-alliance/dpa/AP Images)

New year, new CEOs for Covid vac­cine mak­ers Cure­Vac and No­vavax

Two biotech com­pa­nies that have been on long jour­neys to push through Covid vac­cines are get­ting new CEOs this year.

Cure­Vac CEO Franz-Wern­er Haas is step­ping aside af­ter three years in the po­si­tion for a new chief who’s com­ing from Sanofi. Alexan­der Zehn­der will join Cure­Vac as CEO of the mR­NA biotech on April 1, leav­ing his cur­rent po­si­tion as glob­al head of on­col­o­gy at Sanofi. Ac­cord­ing to a Cure­Vac rep­re­sen­ta­tive, “it’s cur­rent­ly not planned” that Haas will re­main on the man­age­ment board af­ter step­ping down as CEO.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.